| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
2e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
2e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |